Stoke Therapeutics Inc buy BTIG Research
Start price
14.10.25
/
50%
€26.60
Target price
14.10.26
€33.70
Performance (%)
-1.77%
Price
20:49
€26.13
Summary
This prediction is currently active. With a performance of -1.77%, the BUY prediction for Stoke Therapeutics Inc by BTIG_Research is down slightly. This prediction currently runs until 14.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 8.507% | 8.507% |
| iShares Core DAX® | 1.173% | 4.370% |
| iShares Nasdaq 100 | 2.744% | 12.449% |
| iShares Nikkei 225® | 4.948% | 11.538% |
| iShares S&P 500 | 1.395% | 6.628% |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€27.17
11.05.26
11.05.26
€33.17
11.05.27
11.05.27
-1.80%
20:49
20:49
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€27.60
19.03.26
19.03.26
€33.95
19.03.27
19.03.27
-5.33%
20:49
20:49
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€19.00
05.11.25
05.11.25
€33.93
05.11.26
05.11.26
37.53%
20:49
20:49
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€15.60
18.08.25
18.08.25
€23.93
18.08.26
18.08.26
67.50%
20:49
20:49